InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Price to Earnings (2017 - 2026)

InflaRx's (IFRX) quarterly Price to Earnings came in at 22.23 in Q2 2026, down 565.21% year-over-year from 4.78 in Q2 2025, and down 177.49% quarter-over-quarter from 8.01 in Q1 2026.

Analysis

InflaRx (IFRX) Price to Earnings (2017 - 2026) Analysis & Trends

InflaRx has disclosed Price to Earnings across 10 years of filings, most recently posting 22.23 for Q2 2026.

  • In Q2 2026, Price to Earnings fell 565.21% year-over-year to 22.23; the TTM figure through Jun 2026 stood at 4.01 (down 748.36% YoY), while the FY2025 annual figure was 1.42, up 52.43% from the prior year.
  • Price to Earnings came in at 22.23 for Q2 2026 at InflaRx, down from 8.01 in the prior quarter.
  • In the past five years, Price to Earnings ranged from a high of 0.0 in Q4 2022 to a low of 60.29 in Q2 2022.
  • Average Price to Earnings over 5 years is 10.83, with a median of 6.88 recorded in 2024.
  • Year-over-year, Price to Earnings tumbled 912693.06% in 2023 and surged 68.68% in 2024.
  • Over 5 years, Price to Earnings stood at 0.0 in 2022, then plunged by 912693.06% to 2.04 in 2023, then declined by 28.77% to 2.62 in 2024, then tumbled by 92.09% to 5.04 in 2025, then sank by 341.34% to 22.23 in 2026.
  • Per Business Quant data, the three most recent Price to Earnings figures were 22.23 in Q2 2026, 8.01 in Q1 2026, and 5.04 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.23
Mar 31, 2026 -8.01
Dec 31, 2025 -5.04
Sep 30, 2025 -7.55
Jun 30, 2025 -3.34
Mar 31, 2025 -4.60
Dec 31, 2024 -2.62
Sep 30, 2024 -5.63
Jun 30, 2024 -6.54
Mar 31, 2024 -7.21
Dec 31, 2023 -2.04
Sep 30, 2023 -12.29
Jun 30, 2023 -20.89
Mar 31, 2023 -7.97
Dec 31, 2022 0.00
Sep 30, 2022 -13.80
Jun 30, 2022 -60.29
Mar 31, 2022 -4.87
Dec 31, 2021 0.00
Sep 30, 2021 -4.88